Sphera Funds Management’s Gilead Sciences GILD Stock Holding History

Sphera Funds Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-500,000	Closed	-$32.5M	–	87
2019 Q4	$32.5M	Hold	500,000	–	–	2.68%	8
2019 Q3	$31.7M	Buy	+500,000	New	+$32.7M	4.9%	5
2016 Q4	–	Sell	-39,200	Closed	-$3.1M	–	113
2016 Q3	$3.1M	Buy	39,200 +38,700	+7,740%	+$3.14M	0.51%	51
2016 Q2	$4.17M	Buy	+500	New	+$44.4K	1.08%	25
2015 Q1	–	Sell	-394,200	Closed	-$3.95M	–	153
2014 Q4	$3.95M	Buy	394,200 +200,000	+103%	+$20.7M	0.67%	44
2014 Q3	$20.7M	Buy	194,200 +192,200	+9,610%	+$18.8M	2.55%	13
2014 Q2	$2.01M	Hold	2,000	–	–	0.49%	48
2014 Q1	$1.14M	Buy	+2,000	New	+$157K	0.26%	86

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sphera Funds Management's GILD Position: Q1 2024 in Review

Sphera Funds Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 20,000 shares — an estimated $1.62M sold.

Sphera Funds Management first reported a position in GILD in Q4 2013 and held it in 22 quarters. The position peaked at $37.5M in Q2 2015. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

Sphera Funds Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
Sphera Funds Management sold 20,000 Gilead Sciences shares in Q1 2024, an estimated $1.62M.
Sphera Funds Management first reported a position in Gilead Sciences in Q4 2013 and held it in 22 quarters.
Sphera Funds Management's Gilead Sciences position peaked at $37.5M in Q2 2015.
1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Sphera Funds Management's 13F filing for Q1 2024, filed 15 May 2024.